Key Metrics
CiteScore 

12.9
Eigenfactor 

0.01 - 0.05
Impact Factor 

5 - 10
SJR 

Q1Drug Discovery

SNIP 

1.42
Recommended pre-submission checks
Powered by 

Topics Covered on Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | CELL PRESS |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | USD 3900 |
| Publication Time | 20 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | American Society of Gene & Cell Therapy |
| Frequency | Quarterly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Publication Time | 20 |
| Waiver Policy | Visit website |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Molecular Therapy - Nucleic Acids ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Molecular Therapy - Nucleic Acids
Pyroptosis as a novel therapeutic target in glioblastoma multiforme: Mechanisms, molecular insights, and therapeutic potential.
- 8 Sep 2026
- Molecular therapy. Nucleic acids
Targeted gene editing of PCCA pseudoexon using CRISPR-Cas12a for potential therapy in propionic acidemia.
- 8 Sep 2026
- Molecular therapy. Nucleic acids
Advances in ex vivo mRNA-based gene transfer for cell-based cancer immunotherapy.
- 8 Sep 2026
- Molecular therapy. Nucleic acids
A versatile VLP-mediated CRISPR-RNP platform for precise genome editing and durable epigenome silencing in cancer.
- 8 Sep 2026
- Molecular therapy. Nucleic acids
Decoding preeclampsia: A fusion of multi-view machine learning and multi-omics to identify putative inflammation-related mechanisms.
- 8 Sep 2026
- Molecular therapy. Nucleic acids
Understanding the biological limits of hybridization-dependent siRNA off-target interactions.
- 8 Sep 2026
- Molecular therapy. Nucleic acids
Pyroptosis as a novel therapeutic target in glioblastoma multiforme: Mechanisms, molecular insights, and therapeutic potential.
- 8 Sep 2026
- Molecular therapy. Nucleic acids
Targeted gene editing of PCCA pseudoexon using CRISPR-Cas12a for potential therapy in propionic acidemia.
- 8 Sep 2026
- Molecular therapy. Nucleic acids
Advances in ex vivo mRNA-based gene transfer for cell-based cancer immunotherapy.
- 8 Sep 2026
- Molecular therapy. Nucleic acids
A versatile VLP-mediated CRISPR-RNP platform for precise genome editing and durable epigenome silencing in cancer.
- 8 Sep 2026
- Molecular therapy. Nucleic acids
Decoding preeclampsia: A fusion of multi-view machine learning and multi-omics to identify putative inflammation-related mechanisms.
- 8 Sep 2026
- Molecular therapy. Nucleic acids
Understanding the biological limits of hybridization-dependent siRNA off-target interactions.
- 8 Sep 2026
- Molecular therapy. Nucleic acids